Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Development of Indigenous COVID-19 Vaccine is a Big Challenge: BRIN

Translator

Antara

16 January 2022 09:48 WIB

Scientists work in the Merah Putih vaccine research facility of the Bio Farma office in Bandung, Wednesday, August 12, 2020. ANTARA/Dhemas Reviyanto

TEMPO.CO, Jakarta - Developing the Merah Putih COVID-19 vaccine is a big challenge as no single country has experience in developing such a vaccine from scratch, chief of the National Research and Innovation Agency (BRIN) has said.

"Actually, what is more important is to give opportunities to our researchers to gain experience in developing vaccines,” Laksana Tri Handoko said in Jakarta on Saturday.

The COVID-19 pandemic has offered momentum and challenge to researchers to create COVID-19 vaccines to meet domestic needs, he said.

Hence, the Indonesian government has continued to support and facilitate the accelerated development of the indigenous COVID-19 vaccine, he informed.

The development of the Merah Putih (Red and White) COVID-19 vaccine can be considered a form of knowledge investment for allowing Indonesia to produce a variety of vaccines to meet demand in the future, he said.

In general, it takes up to dozens of years to develop a vaccine, he noted. In fact, the development of a vaccine is not automatically fruitful as expected, he said.

Although researchers are required to accelerate the development of COVID-19 vaccines during the pandemic, the vaccines must pass through all processes, in accordance with the required standards, in order to secure emergency-use authorization from the Drug and Food Control Agency (BPOM), Handoko added.

All parties or institutions responsible for developing vaccines are striving to create a COVID-19 vaccine candidate to help meet domestic demand, he said. However, they will all need process and joint efforts to achieve their aim, he added.

Earlier, Handoko had said that, in general, the challenge facing researchers developing the vaccine is not easy because a lot of trials are needed to obtain the most optimal formula to get vaccine seeds.

Producing drugs from vaccine seeds must involve the prescribed procedure, in accordance with the regulation, he added.

The vaccine development process needs deep and complex research and development, Handoko said. Normally, no single research will automatically produce a potential vaccine candidate, he added.

After a vaccine candidate is found, there are still a series of trials such as in vivo trials on animals, and first, second, and third phase clinical tests, production scale, and immunization, he noted.

If a vaccine candidate does not give the desired result when it is tested on animals, then it is reformulated to obtain a vaccine candidate which is really effective in arousing an immune response, he said.

Read: Close to Expiry; Poorer Nations Reject Over 100mn Covid-19 Vaccines

ANTARA



Hajj Pilgrims Urged to Get Vaccinated First Before Departing for Pilgrimage

5 hari lalu

Hajj Pilgrims Urged to Get Vaccinated First Before Departing for Pilgrimage

A health official on Saturday, March 23, 2024, stated that Hajj pilgrims have to get vaccinated before departing for pilgrimage.


Indonesia Delivers 10mn Doses of Polio Vaccines to Afghanistan

21 hari lalu

Indonesia Delivers 10mn Doses of Polio Vaccines to Afghanistan

Afghanistan is one of the countries in the world that is categorized as a polio-endemic country.


Indonesia's Aviation Sector to Recover 100% in 2024 Post COVID-19 Pandemic

21 hari lalu

Indonesia's Aviation Sector to Recover 100% in 2024 Post COVID-19 Pandemic

The recovery in the aviation sector post-COVID-19 pandemic has reached 83 percent.


How India's COVID Lockdowns Impacted Menstrual Health

34 hari lalu

How India's COVID Lockdowns Impacted Menstrual Health

Limited access to period products during India's COVID lockdown highlighted how far public health initiatives have to go when it comes to menstruation


How Do You Eliminate or Eradicate an Infectious Disease?

34 hari lalu

How Do You Eliminate or Eradicate an Infectious Disease?

The COVID-19 pandemic gave the world a crash course in epidemiology and showed in real time how an infectious disease can spread or be contained.


Why Have Efforts to Eradicate TB Been So Slow?

37 hari lalu

Why Have Efforts to Eradicate TB Been So Slow?

Tuberculosis (TB) is one of the world's most deadly infectious diseases - but the COVID-19 pandemic dramatically slowed efforts to eliminate it.


Indonesia Mulls to Collaborate with Brazil's Fiocruz Institute in Developing Dengue Vaccine

45 hari lalu

Indonesia Mulls to Collaborate with Brazil's Fiocruz Institute in Developing Dengue Vaccine

Indonesia is exploring opportunities to collaborate with the Fiocruz Institute from Brazil to reduce dengue cases in Indonesia


Indonesia Pushes for Accelerating Procurement of Newest TB Vaccine

47 hari lalu

Indonesia Pushes for Accelerating Procurement of Newest TB Vaccine

Indonesian Health Minister Budi Gunadi Sadikin is pushing for expediting the provision of the latest Tuberculosis (TB) vaccine


Depok Records 200% Hike in COvid-19 Cases Last December

3 Januari 2024

Depok Records 200% Hike in COvid-19 Cases Last December

Depok Mayor Mohammad Idris revealed that the number of Covid-19 cases in the city surged from 100 to 300 as of December 2023


Today's Top 3 News: Indonesia Still Provides Free COVID-19 Vaccines for Vulnerable Groups, Jakarta Produces 130 Tons of New Year's Eve Waste

2 Januari 2024

Today's Top 3 News: Indonesia Still Provides Free COVID-19 Vaccines for Vulnerable Groups, Jakarta Produces 130 Tons of New Year's Eve Waste

Here is the list of the top 3 news on Tempo English today.